Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
108.50    7.00 (6.90%)
Bid:
106.00
Ask:
111.00
Spread: 5.00 (4.717%)
Market Cap: £65.28m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

New US Government Contracts

20 Nov 2006 07:02

Intercede Group PLC20 November 2006 20 November 2006 INTERCEDE GROUP plc ('Intercede' or 'the Company') Additional US Federal Government Wins Intercede is delighted to inform the market that Operational ResearchConsultants, Inc. (ORC), a wholly owned subsidiary of WidePoint Corporation, anda RSA Security partner, has signed contracts with both the Federal TradeCommission (FTC) and the Federal Housing Finance Board (FHFB) to provideend-to-end managed services in support of their Homeland Security PresidentialDirective 12 (HSPD-12) compliance. ORC's hosted PIVotal ID Card ManagementSystem (CMS), powered by the RSA Card Manager will provide both agencies withend-to-end PIV card enrolment, issuance and management services. RSA CardManager is powered by Intercede's MyID technology under an OEM licence agreementannounced in 2005. Whilst the revenues from these contracts will not bematerial in Intercede's current financial year, the Directors believe that theyare further evidence of the growing market traction being achieved by the MyIDtechnology. Richard Parris, Chairman & Chief Executive of Intercede, commented: "Intercede are delighted that both the FTC and the FHFB have selected MyIDpowered solutions from RSA Security and its partners. This announcementdemonstrates that MyID has the flexibility and scalability to work not only as astand-alone product, but also in a hosted environment, such as ORC, wheremultiple technologies and solutions are integrated to deliver an end-to-endservice." HSPD-12 is one of the most important and high profile security directives ofrecent years. It was issued by President Bush himself in August 2004 andrequired, firstly, the creation of an official federal standard (FIPS-201) forPersonal Identity Verification (PIV), which would prescribe technologies andprocesses for the effective vetting and access control of all federal employeesand contractors. The second requirement of HSPD-12 was for every US FederalAgency to have implemented a PIV solution by the end of October 2006, with allemployees and contractors required to have a personal-201 compliant, smart cardbased identity card one year later. Each of these cards will be issued andmanaged using a management system such as MyID. All HSPD-12 solutions must by mandate only incorporate products that have beenexhaustively tested against by the US General Services Administration (GSA), andincluded in the GSA's Approved Product List for PIV products. Intercedeannounced on 4 October 2006 that it had become the first product in its categoryto achieve this coveted status. It is estimated that almost 8 million identity cards will be issued underHSPD-12. Industry analysts Stanford Group estimate the total value of theprogramme to be worth approximately US$1.3 billion. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). The Group's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates and Open Platformapplets. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology including: Athena Smartcard Solutions,Gemalto, RSA Security, SafeNet, Thales, VeriSign and a variety of systemsintegrators and other security product and service providers. For moreinformation, visit www.intercede.com Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public RelationsArchie Berens Tel. +44 (0)20 7743 6679Kate Catchpole This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jun 20267:00 amRNSFinal Results
15th Jun 20267:00 amRNS-RExtension of Partnership with Swissbit
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.